Tetrahydrofuran
Medchemexpress LLC GSK3182571 | 2135595-04-7 | 99.8% | 495.02 g/mol | C25H31ClN8O | 50MG
GSK3182571 is a non-selective, broad-spectrum pan-kinase inhibitor provided as a solid powder for research use. It is intended for in vitro and cell-based studies to probe kinase networks and off-target effects; not for human use.
- High purity (99.75%).
- Molecular weight 495.02 g/mol.
- Molecular formula C25H31ClN8O.
- Soluble in DMSO at 100 mg/mL (202.01 mM) with ultrasonic aid and pH adjustment.
- Recommended storage: powder -20°C (up to 3 years) or 4°C (up to 2 years).
- White to light yellow solid appearance.
Medchemexpress LLC Rsm-932a | 850807-63-5 | 98.4% | 877.53 g/mol | C46H38Br2Cl2N4 | 10 MG
RSM-932A is a small-molecule choline kinase α (ChoKα) inhibitor used in oncology research. It has demonstrated in vitro antiproliferative activity across multiple tumor-derived cell lines and shown antitumor effects in preclinical models. Supplied as a purified research compound for laboratory use only (not for human or veterinary use).
- Potent choline kinase α inhibitor with demonstrated antiproliferative activity.
- Effective in both in vitro and in vivo preclinical studies.
- High purity suitable for biochemical and cellular assays.
- Molecular weight 877.53 g/mol supports mass-based dosing and analysis.
- Available in small lab-scale quantities for experimental workflows.
- Intended for research use only; not for human or veterinary applications.
![eMolecules 20881-04-3 | Ambeed | (3aR3bS7aR8aR)-2255-Tetramethyltetrahydro-7H-[13]dioxolo[4545]furo[32-d][13]dioxine | 5g | 572926723 | A181940 | MFCD00063224 | 230.26 | C11H18O5](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502484654.JPG-250.jpg)
eMolecules 20881-04-3 | Ambeed | (3aR3bS7aR8aR)-2255-Tetramethyltetrahydro-7H-[13]dioxolo[4545]furo[32-d][13]dioxine | 5g | 572926723 | A181940 | MFCD00063224 | 230.26 | C11H18O5
Pharmablock | 24-dichloro-8-methyl-quinazoline | 25mg | 714320911 | PBXA269 | 39576-83-5 | MFCD11849266 | 213.060 | C9H6Cl2N2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
Medchemexpress LLC Bevurogant (BI 730357) | 1817773-66-2 | 99.5% | C26H28N8O3S | 10MG
Bevurogant (BI 730357) is a retinoid-related orphan receptor-gamma t (RORγt) antagonist supplied as a high-purity research compound for in vitro and preclinical studies of chronic inflammatory diseases.
- Retinoid-related orphan receptor-gamma t antagonist.
- High purity: 99.5%.
- Molecular formula: C26H28N8O3S.
- Offered as a 10 mg research quantity.
- Provided with chemical identifiers for research use.
Medchemexpress LLC Linzagolix | 935283-04-8 | 99.7% | 508.42 | 100 MG
Linzagolix is a potent, non-peptide, and orally active GnRH antagonist. It can be used for uterine fibroids, endometriosis, and adenomyosis research. For research use only, not for sale to patients.
- Potent GnRH antagonist
- Non-peptide compound
- Orally active
- Used for uterine fibroids research
- Used for endometriosis research
- Used for adenomyosis research
Medchemexpress LLC Sar-Arg-Val-Tyr-Val-His-NH2 | 2410957-04-7 | 96.6% | 742.87 | 10 MG
Sar-Arg-Val-Tyr-Val-His-NH2 is a Gq-biased agonist that exhibits 10-fold larger molecular efficacies at the AT1R-Gq fusion protein compared with the AT1R-βarr2 fusion protein. This compound is targeted at the Angiotensin Receptor and acts via the GPCR/G Protein pathway.
- Gq-biased agonist
- Exhibits 10-fold larger molecular efficacies at AT1R-Gq fusion protein
- Targets Angiotensin Receptor
- Acts via GPCR/G Protein pathway
Sigma Aldrich Fine Chemicals Biosciences Tetrahydrofuran inhibitor
Tetrahydrofuran (THf) is widely employed as a solvent. It constitutes the key fragment of various natural products (polyether antibiotics). THf forms a double hydrate with hydrogen sulfide. Crystal structure of this double hydrate has been investigated by three-dimensional single-crystal studies. Butane-1 4-diol is formed as an intermediate during the synthesis of THf. Hot THf is useful for the disSOLUTIONon of polyvinylidene chloride (PVDV).
Glen Research Tetrahydrofuran/Pyridine/Acetic Anhydride, 2000 mL, 0.2 micron filtered, Hazardous material: Yes
This Glen Research product is a high-purity blend of Tetrahydrofuran, Pyridine, and Acetic Anhydride supplied in a 2000 mL volume. It is prepared to exacting specifications for optimal performance in demanding scientific applications, particularly oligonucleotide synthesis. Processed through a 0.2 micron filter during packaging to minimize particulate contamination, this reagent is ideal for ensuring high synthesis efficiency.
- 2000 mL volume
- Primary components include Tetrahydrofuran, Pyridine, and Acetic Anhydride
- Application in oligonucleotide synthesis
- Processed through a 0.2 micron filter
- Prepared to exacting specifications
- Hazardous material
- Stored at controlled room temperature
Medchemexpress LLC 1-(1-ethylpiperidin-4-yl)sulfonyl-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea | 2260969-36-4 | MFCD34579587 | 99.5% | C20H29N3O3S | 10MG
Selnoflast is an orally active, potent, selective, and reversible small-molecule inhibitor of the NLRP3 inflammasome for research use. It is supplied as a white to off-white solid with high reported purity, and the manufacturer provides solubility and storage guidance for preparation and stability in in vitro and preclinical workflows.
- Potent and selective NLRP3 inflammasome inhibition.
- Reversible small-molecule mechanism enabling temporal studies.
- High reported purity for consistent experimental results.
- Solid form suitable for standard laboratory storage and handling.
- Documented solubility in DMSO and alkaline media with preparation notes.
- Specified storage recommendations for powder and solution stability.
- Multiple pack sizes available to support different study scales.
Medchemexpress LLC Linzagolix | 935283-04-8 | 99.7% | 508.4 g/mol | C22H15F3N2O7S | 5 MG
Linzagolix is a non-peptide, orally active gonadotropin-releasing hormone (GnRH) receptor antagonist used in laboratory research into estrogen-dependent conditions such as uterine fibroids, endometriosis, and adenomyosis. Supplied as a small, high-purity solid for research use only (not for human or veterinary use).
- Non-peptide, orally active GnRH antagonist
- Applicable to uterine fibroids, endometriosis, and adenomyosis research
- High chemical purity suitable for analytical and pharmacological studies
- Supplied in a small 5 mg pack for assay development and pilot studies
- Molecular weight 508.4 g/mol
Medchemexpress LLC Taurohyodeoxycholic 10mg | 386523 | 10 MG
Taurohyodeoxycholic acid is a taurine-conjugated 6α-hydroxylated bile acid used in biochemical and preclinical research to investigate liver and intestinal inflammation. It modulates inflammatory markers such as MPO, TNF-α, IL-6, and COX-2, and is applied in models of nonalcoholic fatty liver disease, colitis, and biliary disorders.
- Purity: 99.7%
- Molecular weight: 499.7 g·mol⁻¹
- Chemical formula: C26H45NO6S
- Available as small solid aliquots (for example 10 MG) and as DMSO solution (10 mM x 1 mL)
- Suitable for in vitro assays and in vivo disease models
- Datasheet and SDS available for handling and safety information
Medchemexpress LLC SU 5214 | 186611-04-1 | 98.29% | 251.28 | 50 MG
SU5214 is a potent VEGFR2 inhibitor extracted from patent US5834504A. It has IC50s of 14.8 μM for FLK-1 and 36.7 μM for EGFR. This product is suitable for various laboratory applications.
- Potent VEGFR2 inhibitor
- IC50s of 14.8 μM for FLK-1
- IC50s of 36.7 μM for EGFR
- Extracted from patent US5834504A
Medchemexpress LLC Nateglinide | 105816-04-4 | MFCD00875706 | 99.95% | 100 MG
Nateglinide is a D-phenylalanine derivative that acts as an orally active, short-acting insulinotropic agent and a DPP IV inhibitor. It functions by inhibiting ATP-sensitive K+ channels in pancreatic β-cells and is utilized in the treatment of type 2 (non-insulin-dependent) diabetes mellitus. This product is intended for research use only and is not sold to patients.
- Acts as an orally active, short-acting insulinotropic agent
- Functions as a DPP IV inhibitor
- Inhibits ATP-sensitive K+ channels in pancreatic β-cells
- Used for the treatment of type 2 diabetes mellitus
- Inhibits dinitrophenol-induced KATP currents
- Stimulates human C-peptide secretion
- Improves postprandial glucose concentrations
![Medchemexpress LLC 2-[[5-[(4-fluorophenyl)carbamoyl]pyrimidin-2-yl]sulfanylmethyl]-4-(trifluoromethoxy)phenyl boronic acid | 1648843-04-2 | 99.7% | 10 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000234135.png-250.jpg)
Medchemexpress LLC 2-[[5-[(4-fluorophenyl)carbamoyl]pyrimidin-2-yl]sulfanylmethyl]-4-(trifluoromethoxy)phenyl boronic acid | 1648843-04-2 | 99.7% | 10 MG
SX-682 is an orally bioavailable small-molecule allosteric inhibitor of chemokine receptors CXCR1 and CXCR2 under clinical investigation for oncology indications; it blocks recruitment of myeloid-derived suppressor cells and can enhance T-cell activity.
- Orally bioavailable small-molecule CXCR1/2 inhibitor
- Blocks recruitment of myeloid-derived suppressor cells (MDSCs)
- Enhances T-cell activation and antitumor immune responses
- Demonstrated activity in preclinical tumor models and clinical trials
- Supplied with high purity (typical >99%) and available in small-mass packaging for research